Promising Small Cap Stocks Worth Watching – May 5th

06 May 2026, 10:54 by Doug Wharley · The Cerbat Gem

POET Technologies, Digi Power X, Inflection Point Acquisition Corp. II, Direxion Daily PLTR Bear 1X Shares, and GeneDx are the five Small Cap stocks to watch today, according to MarketBeat’s stock screener tool. Small-cap stocks are shares of publicly traded companies with relatively small market capitalizations—typically roughly $300 million to $2 billion, though exact cutoffs vary by index and market. Investors consider them higher-risk, higher-reward opportunities because they can offer faster growth but also tend to have greater volatility, lower liquidity, and higher business risk than larger, more established companies. These companies had the highest dollar trading volume of any Small Cap stocks within the last several days.

POET Technologies (POET)

POET Technologies Inc. designs, develops, manufactures, and sells discrete and integrated opto-electronic solutions in Canada, the United States, Singapore, and China. It offers integration solutions based on the POET Optical Interposer, a novel platform that allows the seamless integration of electronic and photonic devices into a single multi-chip module using advanced wafer-level semiconductor manufacturing techniques.

Read Our Latest Research Report on POET

Digi Power X (DGXX)

Digihost Technology Inc. operates as a blockchain technology company that focuses on digital currency mining in the United States. It mines for cryptocurrency. The company was incorporated in 2017 and is headquartered in Toronto, Canada.

Read Our Latest Research Report on DGXX

Inflection Point Acquisition Corp. II (IPXX)

Read Our Latest Research Report on IPXX

Direxion Daily PLTR Bear 1X Shares (PLTD)

Read Our Latest Research Report on PLTD

GeneDx (WGS)

GeneDx Holdings Corp., through its subsidiaries, provides genomics-related diagnostic and information services. The company offers Centrellis, an AI-driven health intelligence platform that integrates digital tools and artificial intelligence allowing scientists to ingest and synthesize clinical and genomic data to deliver comprehensive health insights.